Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
7.72
-0.14 (-1.78%)
Nov 21, 2024, 4:00 PM EST - Market closed
Foghorn Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 429 | 272 | 267 | 848 | 721 | - | |
| Market Cap Growth | 146.10% | 2.10% | -68.56% | 17.59% | - | - | |
| Enterprise Value | 201 | 59 | -54 | 807 | 894 | - | |
| Last Close Price | 7.72 | 6.45 | 6.38 | 22.87 | 20.27 | - | |
| PS Ratio | 15.05 | 7.97 | 13.87 | 643.15 | 1677.72 | - | |
| PB Ratio | -18.21 | -3.53 | 2381.22 | 8.76 | 4.93 | - | |
| P/TBV Ratio | - | - | 2381.22 | 8.76 | 4.93 | - | |
| P/FCF Ratio | - | - | 1.39 | - | - | - | |
| P/OCF Ratio | - | - | 1.38 | - | - | - | |
| EV/Sales Ratio | 7.87 | 1.74 | - | 612.13 | 2079.55 | - | |
| Debt / Equity Ratio | -1.38 | -0.58 | 459.88 | 0.60 | 0.56 | -11.65 | |
| Debt / FCF Ratio | - | - | 0.27 | - | - | - | |
| Asset Turnover | 0.08 | 0.10 | 0.04 | 0.00 | 0.00 | - | |
| Quick Ratio | 4.71 | 4.01 | 6.26 | 9.33 | 9.86 | 1.18 | |
| Current Ratio | 4.77 | 4.11 | 6.37 | 9.44 | 10.12 | 1.33 | |
| Return on Equity (ROE) | - | - | -224.54% | -83.37% | -95.05% | -334.21% | |
| Return on Assets (ROA) | -20.45% | -19.53% | -15.84% | -16.24% | -30.82% | -97.64% | |
| Return on Capital (ROIC) | -26660.90% | -691.63% | -70.80% | -32.84% | -35.20% | -117.70% | |
| Earnings Yield | -21.26% | -36.15% | -40.83% | -11.94% | -9.54% | - | |
| FCF Yield | -24.21% | -43.82% | 72.14% | -6.31% | -6.58% | - | |
| Buyback Yield / Dilution | -18.80% | -0.92% | -11.89% | -236.49% | -163.53% | -42.25% | |
| Total Shareholder Return | -18.80% | -0.92% | -11.89% | -236.49% | -163.53% | -42.25% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.